3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
6
Gynecologic
5
Head & Neck
3
Gastrointestinal
3
Genitourinary
2
Dermatologic
2
Breast
2
Thoracic
1
Endocrine
1
CNS
1
Conditions
Lung Neoplasms
102
Carcinoma, Non-Small-Cell Lung
84
Breast Neoplasms
16
Neoplasm Metastasis
14
Melanoma
14
Brain Neoplasms
14
Small Cell Lung Carcinoma
13
Esophageal Neoplasms
10
Colorectal Neoplasms
9
Carcinoma, Renal Cell
9
Pancreatic Neoplasms
8
Ovarian Neoplasms
8
Adenocarcinoma of Lung
8
Prostatic Neoplasms
7
Carcinoma, Hepatocellular
7
Colonic Neoplasms
6
Stomach Neoplasms
5
Carcinoma, Transitional Cell
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Thyroid Neoplasms
4
Sarcoma, Kaposi
4
Rectal Neoplasms
4
Meningeal Carcinomatosis
4
Squamous Cell Carcinoma of Head and Neck
3
Neoplasms
3
Lymphoma
3
Head and Neck Neoplasms
3
HIV Infections
3
Carcinoma, Medullary
3
Interventions
Specimen Handling
2
sargramostim
1
rucaparib
1
pembrolizumab
1
belinostat
1
X-Rays
1
Tissue Banks
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Fluorouracil
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Blood Specimen Collection
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
Magnetic Resonance Spectroscopy
×
Thoracic
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled